Vitasora Health Limited (VHL.AX)
ASX · AUD · Healthcare · Health Information Services
A$0.013 (+8.33%) as of
Key statistics
- Market cap
- 30.53M
- Forward P/E
- -13.00
- EPS (TTM)
- -0.0100
- Dividend yield
- 0.00%
- 52-week range
- 0.0090 – 0.0320
- Beta
- -0.31
- Revenue (TTM)
- 4.84M
- Profit margin
- -219.22%
- Volume
- 1.81M
About Vitasora Health Limited
Vitasora Health Limited engages in the research, development, and commercialization of medical devices in Australia and the United States. The company offers wheezo device. It is also involved in the production of mobile health applications. In addition, the company provides solutions for managing chronic diseases, including cardiovascular, diabetes, chronic obstructive pulmonary disease, and obesity. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company is headquartered in Melbourne, Australia.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Melbourne, VIC, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.